J.P. Morgan Private Wealth Advisors LLC Has $982,000 Holdings in Haleon plc (NYSE:HLN)

J.P. Morgan Private Wealth Advisors LLC boosted its holdings in Haleon plc (NYSE:HLNFree Report) by 19.2% during the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 117,914 shares of the company’s stock after buying an additional 19,000 shares during the period. J.P. Morgan Private Wealth Advisors LLC’s holdings in Haleon were worth $982,000 as of its most recent SEC filing.

Other institutional investors also recently added to or reduced their stakes in the company. Farther Finance Advisors LLC increased its position in Haleon by 79.3% in the 2nd quarter. Farther Finance Advisors LLC now owns 2,986 shares of the company’s stock worth $25,000 after buying an additional 1,321 shares during the period. Washington Trust Advisors Inc. grew its holdings in shares of Haleon by 353.3% during the 3rd quarter. Washington Trust Advisors Inc. now owns 2,960 shares of the company’s stock worth $25,000 after purchasing an additional 2,307 shares in the last quarter. CoreFirst Bank & Trust acquired a new stake in shares of Haleon during the 4th quarter worth approximately $26,000. Barclays PLC grew its holdings in shares of Haleon by 56.4% during the 2nd quarter. Barclays PLC now owns 3,317 shares of the company’s stock worth $28,000 after purchasing an additional 1,196 shares in the last quarter. Finally, Resurgent Financial Advisors LLC acquired a new stake in shares of Haleon during the 4th quarter worth approximately $29,000. 6.67% of the stock is owned by institutional investors.

Haleon Trading Up 0.4 %

Shares of NYSE:HLN opened at $8.17 on Tuesday. The business’s 50 day moving average is $8.30 and its 200-day moving average is $8.28. The company has a debt-to-equity ratio of 0.53, a current ratio of 0.84 and a quick ratio of 0.54. Haleon plc has a 1-year low of $7.49 and a 1-year high of $9.05.

Wall Street Analyst Weigh In

Separately, Morgan Stanley initiated coverage on Haleon in a report on Wednesday, November 1st. They set an “overweight” rating on the stock. Two equities research analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy”.

Read Our Latest Stock Report on HLN

Haleon Company Profile

(Free Report)

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements.

Featured Stories

Want to see what other hedge funds are holding HLN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Haleon plc (NYSE:HLNFree Report).

Institutional Ownership by Quarter for Haleon (NYSE:HLN)

Receive News & Ratings for Haleon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Haleon and related companies with MarketBeat.com's FREE daily email newsletter.